BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $92,300,000 | +89.7% | 610,571 | +82.9% | 0.28% | +79.1% |
| Q2 2022 | $48,644,000 | +916.6% | 333,839 | +869.2% | 0.16% | +690.0% |
| Q3 2021 | $4,785,000 | +309.7% | 34,446 | +152.8% | 0.02% | +233.3% |
| Q4 2020 | $1,168,000 | -77.1% | 13,627 | -88.9% | 0.01% | -82.9% |
| Q3 2019 | $5,099,000 | +19.6% | 122,231 | +25.6% | 0.04% | +29.6% |
| Q2 2019 | $4,263,000 | -56.5% | 97,341 | -63.2% | 0.03% | -62.0% |
| Q4 2018 | $9,795,000 | +3527.8% | 264,861 | +3577.6% | 0.07% | +7000.0% |
| Q3 2018 | $270,000 | -51.9% | 7,202 | -49.3% | 0.00% | -66.7% |
| Q2 2018 | $561,000 | – | 14,207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 450,422 | $6,251,857 | 14.11% |
| Liontrust Investment Partners LLP | 134,659 | $7,478,961 | 0.13% |
| Birchview Capital, LP | 7,365 | $102 | 0.07% |
| FNY Investment Advisers, LLC | 250 | $3 | 0.00% |
| FNY Investment Advisers, LLC | 18 | $0 | 0.00% |
| FNY Investment Advisers, LLC | 56 | $0 | 0.00% |
| McElhenny Sheffield Capital Management, LLC | 31 | $430 | 0.00% |
| Blue Trust, Inc. | 65 | $10 | 0.00% |
| IFP Advisors, Inc | 1 | $1 | 0.00% |